Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-01 Lucchino David L. President and CEO Sale −8,900 $43.71 $389K 310,788
2021-02-01 Lucchino David L. President and CEO Sale −2,702 $44.58 $120K 308,086
2021-02-01 Lucchino David L. President and CEO Exercise or conversion · Stock Option −33,102 204,549
2021-01-29 McCubbin Quentin Chief Manufacturing Officer Grant or award · Stock Option +90,000 90,000
2021-01-27 Lucchino David L. President and CEO Exercise or conversion +9,196 $0.61 $6K 317,282
2021-01-27 Lucchino David L. President and CEO Sale −9,196 $42.50 $391K 308,086
2021-01-27 Lucchino David L. President and CEO Exercise or conversion · Stock Option −9,196 237,651
2021-01-27 Loose Christopher R. Chief Scientific Officer Sale −8,000 $42.50 $340K 31,782
2021-01-15 Loose Christopher R. Chief Scientific Officer Grant or award · Stock Option +70,000 70,000
2021-01-15 Lucchino David L. President and CEO Grant or award · Stock Option +200,000 200,000
2021-01-15 Arnold Wendy S Chief People Officer Grant or award · Stock Option +75,000 75,000
2021-01-15 LeBel Carl Chief Development Officer Grant or award · Stock Option +75,000 75,000
2021-01-15 Hilt Dana Charles Chief Medical Officer Grant or award · Stock Option +70,000 70,000
2021-01-15 PFREUNDSCHUH PETER P. Chief Financial Officer Grant or award · Stock Option +10,000 10,000
2021-01-06 Lucchino David L. President and CEO Exercise or conversion +27,586 $0.61 $17K 335,672
2021-01-06 Lucchino David L. President and CEO Sale −900 $36.13 $33K 334,772
2021-01-06 Lucchino David L. President and CEO Sale −10,707 $37.45 $401K 324,065
2021-01-06 Lucchino David L. President and CEO Sale −4,164 $38.26 $159K 319,901
2021-01-06 Lucchino David L. President and CEO Sale −2,319 $39.37 $91K 317,582
2021-01-06 Lucchino David L. President and CEO Sale −9,496 $40.00 $380K 308,086

Page 25 of 34 · 670 trades